BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Spirus Medical, Inc. Raises $8.5 Million in Preferred Equity Financing


4/19/2007 10:23:03 AM

STOUGHTON, Mass., April 18 /PRNewswire/ -- Spirus Medical, Inc. (www.spirusmed.com), a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, urology and gynecology, announced today that it has raised $8.5 million in Series B Convertible Preferred Stock financing. BioVentures Investors, Point Judith Capital and Village Ventures, along with a group of accredited individual investors, participated in the financing.

"This financing will allow us to continue to commercialize our innovative EAS(TM) platform technology for a growing array of applications," said Steve Tallarida, Spirus Medical president and chairman.

Spirus Medical has developed a revolutionary Endoluminal Advancement System (EAS(TM)) that uses a soft spiral component, fixed on an active, flexible overtube to facilitate a more efficient approach to endoscopy. In November 2006, Spirus Medical launched its first two products for colonoscopy; the Endo-Ease Advantage(TM) and the longer Endo-Ease Vista(TM). In December 2006, the company received the CE Mark, allowing it to market its colonoscopy products in Europe.

Spirus Medical also has received 510(k) clearance for its EndoEase Discovery(TM) SB product for enteroscopy and will launch that product later this year.

"Endoscopic access to the small bowel remains a tedious and lengthy procedure, and Spirus has developed a solution that will be a significant improvement over current technology. We believe the Endo-Ease Discovery SB represents a major breakthrough, enabling physicians to easily visualize and provide therapy to the small bowel using a conventional enteroscope," said Marc Goldberg, managing director of BioVentures Investors.

Spirus Medical, Inc., headquartered in Stoughton, Mass., was incubated and founded in 2005 by STD Med, Inc., a Stoughton-based manufacturer and developer of medical technologies. In addition to Spirus, other companies that began at STD Med are Angiolink Corporation, Arthrosurface Incorporated, and Cardiosolutions, Inc. For more on Spirus Medical, visit www.spirusmed.com

Spirus Medical, Inc.

CONTACT: Tony Resendes, Vice President of Marketing of Spirus Medical,Inc., +1-781-297-7220



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES